Literature DB >> 18784316

Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test.

Matthew P Stevens1, Suzanne M Garland, Sepehr N Tabrizi.   

Abstract

An automated platform (BeeBlot) was evaluated in parallel with the recommended protocol for the hybridization and detection steps of the Roche Linear Array human papillomavirus (HPV) genotyping test using DNA from 143 cervical specimens. Genotyping profiles showed 100% concordance between the methods, suggesting that automation could complement the Roche Linear Array for enhanced speed and reproducibility.

Entities:  

Mesh：

Year:  2008        PMID： 18784316      PMCID： PMC2576620          DOI： 10.1128/JCM.01169-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.

Authors:  M Schiffman; R Herrero; A Hildesheim; M E Sherman; M Bratti; S Wacholder; M Alfaro; M Hutchinson; J Morales; M D Greenberg; A T Lorincz
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

Review 3.  The future of HPV testing in clinical laboratories and applied virology research.

Authors:  F Coutlée; M H Mayrand; D Provencher; E Franco
Journal:  Clin Diagn Virol       Date:  1997-08

4.  Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.

Authors:  K L Wallin; F Wiklund; T Angström; F Bergman; U Stendahl; G Wadell; G Hallmans; J Dillner
Journal:  N Engl J Med       Date:  1999-11-25       Impact factor: 91.245

5.  Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.

Authors:  Matthew P Stevens; Elice Rudland; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

6.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.

Authors:  Dennis van Hamont; Maaike A P C van Ham; Judith M J E Bakkers; Leon F A G Massuger; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

8.  The laboratory diagnosis of genital human papillomavirus infections.

Authors:  François Coutlée; Danielle Rouleau; Alex Ferenczy; Eduardo Franco
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

9.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

Authors:  G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

Review 10.  The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity.

Authors:  Peter J F Snijders; Adriaan J C van den Brule; Chris J L M Meijer
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996
View more
  9 in total

1.  Effect of ThinPrep preparation on human papillomavirus detection and genotyping in rectal samples by PCR.

Authors:  Sepehr N Tabrizi; Matthew P Stevens; Marina T van Leeuwen; Claire M Vajdic; Leon P Botes; Gabriele Medley; Richard Hillman; Andrew Grulich; Suzanne M Garland
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

2.  Comparison of the DiagCor GenoFlow Human Papillomavirus Array Test and Roche Linear Array HPV Genotyping Test.

Authors:  Fiona K Y Wong; Johannes C Y Ching; Joseph K F Chow
Journal:  Open Virol J       Date:  2010-11-03

3.  Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program.

Authors:  Suzanne M Garland; Julia M L Brotherton; John R Condon; Peter B McIntyre; Matthew P Stevens; David W Smith; Sepehr N Tabrizi
Journal:  BMC Med       Date:  2011-09-13       Impact factor: 8.775

4.  Reduction in HPV 16/18 prevalence among young women following HPV vaccine introduction in a highly vaccinated district, Japan, 2008-2017.

Authors:  Akihiro Karube; Fumiko Saito; Enami Nakamura; Akihiro Shitara; Natsuki Ono; Megumi Konno; Daisuke Tamura; Daisuke Nagao
Journal:  J Rural Med       Date:  2019-05-30

5.  Oral human papillomavirus in men having sex with men: risk-factors and sampling.

Authors:  Tim R H Read; Jane S Hocking; Lenka A Vodstrcil; Sepehr N Tabrizi; Michael J McCullough; Andrew E Grulich; Suzanne M Garland; Catriona S Bradshaw; Marcus Y Chen; Christopher K Fairley
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

6.  Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study).

Authors:  Elisa J Young; Sepehr N Tabrizi; Julia Ml Brotherton; John D Wark; Jan Pyman; Marion Saville; C David Wrede; Yasmin Jayasinghe; Jeffrey Tan; Dorota M Gertig; Marian Pitts; Suzanne M Garland
Journal:  BMC Cancer       Date:  2013-06-19       Impact factor: 4.430

7.  HIV associated high-risk HPV infection among Nigerian women.

Authors:  Sally N Akarolo-Anthony; Maryam Al-Mujtaba; Ayotunde O Famooto; Eileen O Dareng; Olayinka B Olaniyan; Richard Offiong; Cosette M Wheeler; Clement A Adebamowo
Journal:  BMC Infect Dis       Date:  2013-11-05       Impact factor: 3.090

8.  Age-specific prevalence of human papilloma virus infection among Nigerian women.

Authors:  Sally N Akarolo-Anthony; Ayo O Famooto; Eileen O Dareng; Olayinka B Olaniyan; Richard Offiong; Cosette M Wheeler; Clement A Adebamowo
Journal:  BMC Public Health       Date:  2014-06-27       Impact factor: 3.295

9.  A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in australia.

Authors:  Surabhi S Liyanage; Eva Segelov; Aisha Malik; Suzanne M Garland; Sepehr N Tabrizi; Eleanor Cummins; Holly Seale; Bayzidur Rahman; Aye Moa; Andrew P Barbour; Philip J Crowe; C Raina MacIntyre
Journal:  J Oncol       Date:  2014-04-28       Impact factor: 4.375
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.